Hirschsprung disease
HERSH-sproong dih-zeez
Also known as: congenital aganglionic megacolon
At a Glance
What is Hirschsprung disease?
Hirschsprung disease is a condition that affects the large intestine and causes problems with passing stool. It is present at birth and results from missing nerve cells in the muscles of the baby's colon. The absence of these nerve cells means that the muscles in the bowel wall cannot relax, leading to a blockage. Early symptoms include a swollen belly, vomiting, and constipation. If not treated, it can lead to severe complications like enterocolitis, which is an infection of the intestines. Early diagnosis is crucial to prevent these complications and improve outcomes. The condition can be challenging for families, as it often requires surgery and ongoing medical care. With treatment, most children can lead normal lives, although some may have long-term bowel problems. Daily life for affected individuals may include dietary adjustments and regular medical follow-ups. The prognosis is generally good with early intervention. However, some children may experience complications such as bowel obstruction or infection. Support from healthcare providers and family is essential for managing the condition effectively.
Medical Definition
Hirschsprung disease is a congenital disorder characterized by the absence of ganglion cells in the distal colon, resulting in a functional obstruction. Pathologically, it involves the failure of neural crest cells to migrate completely during intestinal development, leading to aganglionosis. Histological findings include the absence of ganglion cells and hypertrophy of nerve fibers in the affected segment. The disease is classified based on the length of the aganglionic segment, ranging from short-segment to long-segment disease. Epidemiologically, it occurs in approximately 1 in 5,000 live births, with a higher prevalence in males. The disease course can vary, but early surgical intervention typically results in a favorable outcome.
Hirschsprung disease Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Chronic constipation in Hirschsprung disease manifests as infrequent bowel movements and difficulty passing stools. It is caused by the absence of ganglion cells in the distal colon, leading to a lack of peristalsis and bowel obstruction. Over time, constipation can lead to abdominal distension and discomfort. This symptom significantly affects daily life by causing pain and distress, and management often requires surgical intervention to remove the affected bowel segment.
Abdominal distension occurs as a result of gas and stool accumulation in the bowel. The biological mechanism involves the lack of nerve cells that normally help move contents through the intestines. As the condition progresses, the distension can become more pronounced and painful. It affects daily life by causing discomfort and may require medical or surgical treatment to relieve the pressure.
Failure to thrive is observed as poor weight gain and growth in infants with Hirschsprung disease. This occurs due to malabsorption and inadequate nutrient intake secondary to bowel obstruction. Over time, the child's growth may be significantly stunted if the condition is not addressed. It impacts daily life by affecting overall health and development, necessitating nutritional support and surgical correction.
Common
Vomiting in Hirschsprung disease is often a result of bowel obstruction and increased abdominal pressure. The absence of ganglion cells leads to a functional blockage, causing food and fluids to be expelled. As the condition worsens, vomiting may become more frequent and severe. It disrupts daily life by causing dehydration and electrolyte imbalances, requiring medical management and sometimes surgical intervention.
Enterocolitis presents as inflammation and infection of the bowel, often with diarrhea and fever. It is caused by bacterial overgrowth due to stagnant bowel contents. This condition can progress rapidly and become life-threatening if not treated promptly. It affects daily life by causing severe illness and requires immediate medical attention, often involving antibiotics and supportive care.
Delayed passage of meconium is noted when a newborn fails to pass their first stool within 48 hours of birth. This occurs due to the lack of nerve cells in the rectum and colon, preventing normal bowel movements. If untreated, it can lead to bowel obstruction and other complications. It impacts daily life by necessitating medical evaluation and potential surgical intervention to resolve the obstruction.
Less Common
Bowel perforation is a rare but serious complication where a hole forms in the bowel wall. It results from increased pressure and distension in the bowel due to obstruction. This can lead to peritonitis and sepsis, which are life-threatening conditions. Immediate surgical intervention is required to repair the perforation and prevent further complications.
Rectal bleeding may occur as a result of mucosal damage from chronic constipation and straining. The biological mechanism involves irritation and potential tearing of the bowel lining. Over time, this can lead to anemia and further complications if not addressed. It affects daily life by causing discomfort and may require medical evaluation to determine the underlying cause and appropriate treatment.
What Causes Hirschsprung disease?
Hirschsprung disease is primarily caused by mutations in the RET proto-oncogene located on chromosome 10q11.2. The RET gene encodes a receptor tyrosine kinase that is crucial for the development of the enteric nervous system. Mutations in RET can lead to a loss of function, disrupting the signaling pathways necessary for the migration, proliferation, and differentiation of neural crest cells. As a result, there is a failure in the formation of enteric ganglia, leading to aganglionosis in the distal colon. This absence of ganglion cells causes a lack of peristalsis, resulting in bowel obstruction. The disrupted signaling can also affect other pathways, potentially involving the endothelin receptor type B (EDNRB) and its ligand endothelin-3 (EDN3), further complicating the disease phenotype. Neuroinflammation may occur as the body attempts to compensate for the lack of neural input, potentially exacerbating tissue damage. The absence of enteric neurons can lead to secondary degeneration of surrounding tissues due to chronic obstruction and inflammation. Symptoms typically present as severe constipation or intestinal obstruction in neonates, as these are the immediate consequences of aganglionosis. The variability in disease severity among patients can be attributed to the type and location of the mutations, as well as the involvement of modifier genes and environmental factors. Some patients may have short-segment disease, while others have long-segment involvement, affecting the extent of surgical intervention required. The immune response may also vary, influencing the degree of inflammation and subsequent tissue damage. In some cases, mutations in other genes such as EDNRB, EDN3, and SOX10 can contribute to the phenotype, leading to syndromic forms of the disease. The interplay between genetic mutations and environmental factors ultimately determines the clinical presentation and progression of Hirschsprung disease.
How is Hirschsprung disease Diagnosed?
Typical age of diagnosis: Hirschsprung disease is typically diagnosed in the neonatal period, often within the first few days of life, when infants present with symptoms such as failure to pass meconium, abdominal distension, and vomiting.
Clinicians look for signs of bowel obstruction, such as abdominal distension and failure to pass meconium. A detailed history includes prenatal and family history of similar conditions. Physical examination may reveal a distended abdomen and explosive expulsion of stool upon rectal examination. This step helps determine the likelihood of Hirschsprung disease and the need for further diagnostic testing.
A contrast enema is typically used to identify the transition zone between dilated proximal bowel and narrow distal bowel. The imaging may show a classic 'transition zone' which suggests Hirschsprung disease. These findings help confirm the diagnosis by visualizing the anatomical defect. Differential diagnoses such as meconium plug syndrome or small left colon syndrome can be excluded based on imaging characteristics.
Rectal biopsy is the definitive laboratory test, looking for the absence of ganglion cells. Histological examination reveals aganglionosis in the affected bowel segment. Abnormal results show hypertrophic nerve trunks and absence of ganglion cells, confirming Hirschsprung disease. These results guide the surgical planning for resection of the aganglionic segment.
Genetic testing may involve sequencing the RET gene, among others, to identify mutations associated with Hirschsprung disease. Mutations such as missense or nonsense mutations can be found. Positive results confirm the diagnosis and provide information for genetic counseling. They also help in assessing the risk of recurrence in future siblings and guide family planning.
Hirschsprung disease Treatment Options
Prokinetic agents are used to enhance gastrointestinal motility. These drugs work by stimulating the enteric nervous system to increase peristalsis. Specific drugs like metoclopramide may be used, although evidence for efficacy in Hirschsprung disease is limited. Clinical trials have shown variable results, and these drugs are often adjunctive to surgical treatment. Side effects can include extrapyramidal symptoms and gastrointestinal discomfort.
Techniques include bowel training and enemas to promote regular bowel movements. The goal is to improve bowel function and prevent constipation. Sessions are typically conducted daily or several times a week, depending on the severity of symptoms. Outcomes are measured by the frequency and consistency of bowel movements. Long-term benefits include improved quality of life and reduced risk of enterocolitis.
Surgery is indicated for removing the aganglionic segment of the bowel. The procedure involves resecting the affected bowel and anastomosing the healthy bowel to the anus. Expected benefits include relief of obstruction and restoration of normal bowel function. Surgical risks include anastomotic leaks, strictures, and infection. Post-operative care requires monitoring for complications and gradual reintroduction of feeding.
The care team typically includes pediatric surgeons, gastroenterologists, nutritionists, and psychologists. Interventions focus on nutritional support, bowel management, and psychosocial support. Strategies include family education on disease management and coping strategies. Long-term monitoring involves regular follow-ups to assess growth, development, and bowel function. This comprehensive approach aims to improve overall outcomes and quality of life for the patient and family.
When to See a Doctor for Hirschsprung disease
- Severe abdominal distension — this may indicate a bowel obstruction, which requires immediate medical attention.
- Fever with vomiting — could suggest enterocolitis, a potentially life-threatening complication.
- Bloody diarrhea — may signal serious intestinal inflammation or infection, needing urgent care.
- Chronic constipation — may indicate worsening of bowel function, and a doctor should evaluate the need for intervention.
- Failure to thrive — suggests nutritional deficiencies or complications, requiring medical assessment.
- Recurrent abdominal pain — could indicate underlying issues with bowel function, warranting further investigation.
- Mild constipation — monitor dietary intake and hydration, and consult a doctor if it persists.
- Occasional abdominal discomfort — keep track of symptoms and dietary habits, and seek advice if it worsens.
Hirschsprung disease — Frequently Asked Questions
Is this condition hereditary?
Hirschsprung disease can be hereditary, often following an autosomal dominant or recessive pattern. The probability of passing it to children varies depending on the specific genetic mutation. De novo mutations can occur, meaning the condition can appear without a family history. Carriers may not show symptoms but can pass the mutation to offspring. Genetic counseling is recommended to understand individual risks and implications.
What is the life expectancy for someone with this condition?
Life expectancy can be normal with early diagnosis and proper treatment. Prognosis is generally better if the condition is diagnosed and managed early in life. Mortality is often due to complications like enterocolitis or bowel obstruction. Surgical treatment significantly improves survival rates. Realistic expectations include a need for ongoing medical follow-up and potential lifestyle adjustments.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, imaging studies, and rectal biopsy. The time from first symptoms to diagnosis can vary, often taking weeks to months. Pediatric gastroenterologists and surgeons are typically involved in the diagnostic process. Delays can occur due to symptom overlap with other conditions. A rectal biopsy confirming absence of ganglion cells is definitive for diagnosis.
Are there any new treatments or clinical trials available?
Research is ongoing, with promising developments in stem cell therapy and regenerative medicine. Gene therapy is being explored as a potential future treatment. Clinical trials can be found on ClinicalTrials.gov by searching 'Hirschsprung disease'. Discussing trial eligibility and potential benefits with a healthcare provider is essential. New treatments may take years to become widely available, pending research outcomes.
How does this condition affect daily life and activities?
Hirschsprung disease can impact mobility and self-care due to bowel management needs. Educational performance may be affected by frequent medical appointments or discomfort. Social and emotional challenges include coping with a chronic condition and potential stigma. Family burden can be significant, requiring time and resources for care. Supportive measures include dietary management, psychological support, and educational accommodations.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Diagnosis of Hirschsprung Disease.
Ambartsumyan L, Smith C, Kapur RP · Pediatr Dev Pathol · 2020 · PMID: 31791203
- 2.Hirschsprung disease.
Haricharan RN, Georgeson KE · Semin Pediatr Surg · 2008 · PMID: 19019295
- 3.Hirschsprung disease and Paediatric Intestinal Pseudo-obstruction.
Chanpong A, Borrelli O, Thapar N · Best Pract Res Clin Gastroenterol · 2022 · PMID: 35331399
- 4.Hirschsprung disease.
Langer JC · Curr Opin Pediatr · 2013 · PMID: 23615177
- 5.Hirschsprung Disease for the Practicing Surgical Pathologist.
Matsukuma K, Gui D, Saadai P · Am J Clin Pathol · 2023 · PMID: 36565211
- 6.Forward-Perspectives in Pediatric Pathology: Hirschsprung Disease.
Rogers BB · Pediatr Dev Pathol · 2020 · PMID: 31822165
- 7.Hirschsprung Disease.
Mahon M, Khlevner J · Pediatr Rev · 2021 · PMID: 36017952
- 8.Hirschsprung disease.
Dasgupta R, Langer JC · Curr Probl Surg · 2004 · PMID: 15614238
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-27